Search research articles
Contact Us
Filters
Showing results (1-10 of 392) with videos related to
Page
of 40
Sort By:
European Urology
|
December 30, 2014
Observed Advantages of the STAMPEDE Study Design
Howard I Scher
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 27, 2014
Building on Prostate Cancer Working Group 2 to change the paradigm from palliation to cure
Howard I Scher
Cancer
|
January 28, 2003
Prostate carcinoma: defining therapeutic objectives and improving overall outcomes
Howard I Scher
Lancet (London, England)
|
March 31, 2016
Defining new standards of care for men with prostate cancer
Howard I Scher
Clinical Advances in Hematology & Oncology : H&O
|
September 16, 2005
Current management of hormone-refractory prostate cancer
Howard I Scher
Clinical Chemistry
|
August 3, 2010
Detection of androgen receptor mutations in circulating tumor cells: highlights of the long road to clinical qualification
Hans Lilja, Howard I Scher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2002
Picking the winners in a sea of plenty
Howard I Scher, Glenn Heller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 25, 2009
Bone marrow aspiration for disseminated tumor cell detection: a must-have test or is the jury still out?
Howard I Scher, Klaus Pantel
Cancer Journal (Sudbury, Mass.)
|
January 23, 2013
Androgen receptor antagonists in castration-resistant prostate cancer
Dana Rathkopf, Howard I Scher
Annals of Internal Medicine
|
August 9, 2017
Maintaining Bone Health During Hormonal Therapy for Prostate Cancer
Azeez Farooki, Howard I Scher
Page
of 40
Search research articles
Search
Showing results (1-10 of 392) with videos related to
Sort By:
Page
of 40
European Urology
|
December 30, 2014
Observed Advantages of the STAMPEDE Study Design
Howard I Scher
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 27, 2014
Building on Prostate Cancer Working Group 2 to change the paradigm from palliation to cure
Howard I Scher
Cancer
|
January 28, 2003
Prostate carcinoma: defining therapeutic objectives and improving overall outcomes
Howard I Scher
Lancet (London, England)
|
March 31, 2016
Defining new standards of care for men with prostate cancer
Howard I Scher
Clinical Advances in Hematology & Oncology : H&O
|
September 16, 2005
Current management of hormone-refractory prostate cancer
Howard I Scher
Clinical Chemistry
|
August 3, 2010
Detection of androgen receptor mutations in circulating tumor cells: highlights of the long road to clinical qualification
Hans Lilja, Howard I Scher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2002
Picking the winners in a sea of plenty
Howard I Scher, Glenn Heller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 25, 2009
Bone marrow aspiration for disseminated tumor cell detection: a must-have test or is the jury still out?
Howard I Scher, Klaus Pantel
Cancer Journal (Sudbury, Mass.)
|
January 23, 2013
Androgen receptor antagonists in castration-resistant prostate cancer
Dana Rathkopf, Howard I Scher
Annals of Internal Medicine
|
August 9, 2017
Maintaining Bone Health During Hormonal Therapy for Prostate Cancer
Azeez Farooki, Howard I Scher
Page
of 40